| Original language | English (US) |
|---|---|
| Pages (from-to) | 2523-2527 |
| Number of pages | 5 |
| Journal | Mayo Clinic Proceedings |
| Volume | 96 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2021 |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Mayo Clinic Proceedings, Vol. 96, No. 10, 10.2021, p. 2523-2527.
Research output: Contribution to journal › Short survey › peer-review
TY - JOUR
T1 - Ethnicity-Based Disparities in Immune-Mediated Diseases—Time for Action!
AU - Krishna, Mamidipudi Thirumala
AU - Warren, Christopher M.
AU - Jiang, Jialing
AU - Gupta, Ruchi S.
N1 - Funding Information: Grant Support: This work was supported in part by grants R21 AI135705 , R01 AI130348 , and U01 AI138907 from the National Institutes of Health (R.S.G.). Funding Information: Grant Support: This work was supported in part by grants R21 AI135705, R01 AI130348, and U01 AI138907 from the National Institutes of Health (R.S.G.).Potential Competing Interests: Dr Krishna has received grants from MRC CiC, NIHR, FSA and Institute for Global Innovation (University of Birmingham), UK for research unrelated to this manuscript. His department received funds from ALK Abello, Thermofisher, MEDA and other pharmaceutical companies for PracticAllergy course. He received funds to attend EAACI conference. Dr Warren is a consultant for Alladapt Immunotherapeutics, Inc. Dr Gupta is a consultant for AllerGenis, LLC, Aimmune Therapeutics, Genentech, Inc, Before Brands, Inc, Kal?o, Inc, Novartis AG, DBV Technologies, Pfizer Inc, ICER, DOTS Technologies, and Food Allergy & Asthma Research and has received research support from Food Allergy & Asthma Research, Allergy & Asthma Network, Rho, Inc, Aimmune Therapeutics, Mylan Specialty LP, UnitedHealth Group, Thermo Fisher Scientific, Genentech, Inc, and the National Confectioners Association. Dr Jiang reports no competing interests. Funding Information: Potential Competing Interests: Dr Krishna has received grants from MRC CiC, NIHR, FSA and Institute for Global Innovation (University of Birmingham), UK for research unrelated to this manuscript. His department received funds from ALK Abello, Thermofisher, MEDA and other pharmaceutical companies for PracticAllergy course. He received funds to attend EAACI conference. Dr Warren is a consultant for Alladapt Immunotherapeutics, Inc. Dr Gupta is a consultant for AllerGenis, LLC, Aimmune Therapeutics, Genentech, Inc, Before Brands, Inc, Kaléo, Inc, Novartis AG, DBV Technologies, Pfizer Inc, ICER, DOTS Technologies, and Food Allergy & Asthma Research and has received research support from Food Allergy & Asthma Research , Allergy & Asthma Network , Rho, Inc , Aimmune Therapeutics , Mylan Specialty LP , UnitedHealth Group , Thermo Fisher Scientific , Genentech, Inc , and the National Confectioners Association . Dr Jiang reports no competing interests.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85114364683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114364683&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2021.05.024
DO - 10.1016/j.mayocp.2021.05.024
M3 - Short survey
C2 - 34479737
AN - SCOPUS:85114364683
SN - 0025-6196
VL - 96
SP - 2523
EP - 2527
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 10
ER -